NCT02579577

Brief Summary

The population of children with life-limiting illnesses (LLI) in England is increasing and there is growing need to improve the quality of children's palliative care. Families of children with LLI are confronted with many care decisions for their children, such as whether and when to commence artificial nutrition or ventilation. They may also have the opportunity to consider the care that may be appropriate for their child in the future. Despite the important decisions families and professionals are required to make, there is little empirical evidence regarding the process of decision making and future planning for this population. Few studies have investigated the perspectives of multiple stakeholders and none have addressed multiple perspectives longitudinally. Therefore the relational and contextual aspects of decision making and future planning for children with LLI have as yet not been identified. A multiple embedded case study utilising ethnographic methods (semi-structured interviews, observation and notes review) is proposed to address this knowledge gap. Families of children with LLI cared for in either of two participating hospitals will be recruited and followed up for up to 12 months. The family will be invited to nominate 'significant others' (e.g. relatives, friends, health care professionals) who assist them in decision making and future planning, to participate in the study. Outpatient clinic appointments or ward rounds during periods of hospitalisation will be observed and semi-structured interviews will be conducted approximately three times with each participant. Medical notes will be reviewed at the end of the study. This research will enable a better understanding of the experiences and preferences for engaging in decision making and future planning from the perspectives of all stakeholders. It will also provide an awareness of the communication practices involved in discussions and the networks of care surrounding children with LLI, including specific support needs in relation to their role.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2015

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2015

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 19, 2015

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2017

Completed
Last Updated

May 3, 2017

Status Verified

May 1, 2016

Enrollment Period

1.3 years

First QC Date

July 31, 2015

Last Update Submit

May 2, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Semi-Structured Interview Responses

    Interviews will be semi-structured, with a broad opening question asking the participant about the child at the centre of the case; both in terms of their illness and their context (family, personality, values and goals). Although the topics of decision making and future planning will be covered within the interview, the way in which these are initiated are likely to be different for each participant and asked in relation to the responses given to the opening question.

    Up to 24 months

  • Observational fieldnotes

    Observations will occur at clinic appointments and ward rounds and will aim to identify the communication processes involved in decision making and how each individual involved participates.

    Up to 24 months

Study Arms (1)

Decision making cohort

Any people identified as being important within the network of care for children with life-limiting illnesses.

Other: ObservationOther: InterviewsOther: Medical notes review

Interventions

Observation of clinic appointments and ward rounds if the child is admitted to hospital during the study period.

Decision making cohort

Semi-structured interviews will be conducted approximately 3 times during the study period with each participant.

Decision making cohort

The child's electronic medical record will be accessed periodically to identify any planned appointments or periods of hospitalisation and their medical notes will also be reviewed at the end of the study.

Decision making cohort

Eligibility Criteria

Age28 Days+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Each case will be centred around a child with a life-limiting illness and their parents who will have been identified as eligible by their usual care team. Additional significant others who are important in their decision making and future planning will be identified by the family and will ideally include at least one health professional. However, the composition of each case will be determined by the child and family and may involve only them. Nominated 'significant others' may include extended family, peers, ministers of religion, key workers etc.

You may qualify if:

  • Their child must be between 28 days and 18 years old
  • Their child must have a LLI within categories 2-4 (Association for Children with Life-threatening and Terminal Conditions and their Families, 2004) (see page 8)
  • Child must be under the care of a consultant at either of the two NHS Trusts included in the study
  • The parent must be aware of the child's LLI diagnosis
  • Participants must speak English. This is both due to resource constraints and due to the sensitive topic such that difficulties in translating questions sensitively may cause greater distress to participants.
  • Children will be classed as participants if their parent is a participant and consents to their child's medical notes being accessed.
  • For children to participate in the interview component of the study, they must be over the age of 7 years and cognitively able to provide their own assent (or consent, if over 16 years old)
  • Parents must have agreed to the child's participation if they are under 16 years old
  • Participants must speak English or be able to communicate in some way using alternative or augmentative communication.
  • Significant others must have been identified by the eligible child and/or parents as being important in their decision making and future planning
  • Participants must speak English
  • Participants must be over the age of 7 years and provide their own assent alongside parental consent (if under 16 years old) or provide consent if they are over the age of 16 years (in the case of a friend or sibling being nominated as a 'significant other').

You may not qualify if:

  • Families and significant others of children with ACT Category 1 life-threatening illnesses (Conditions for which curative treatment may be feasible but can fail)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Sherwood Forest Hospitals NHS Trust

Mansfield, United Kingdom

Location

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

Location

Sheffield Children's Hospital

Sheffield, United Kingdom

Location

MeSH Terms

Interventions

ObservationInterviews as Topic

Intervention Hierarchy (Ancestors)

MethodsInvestigative TechniquesData CollectionEpidemiologic MethodsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Bridget Johnston, Professor

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2015

First Posted

October 19, 2015

Study Start

October 1, 2015

Primary Completion

January 31, 2017

Study Completion

January 31, 2017

Last Updated

May 3, 2017

Record last verified: 2016-05

Locations